-
Je něco špatně v tomto záznamu ?
Carbohydrate synthesis and biosynthesis technologies for cracking of the glycan code: recent advances
H. Mrázek, L. Weignerová, P. Bojarová, P. Novák, O. Vaněk, K. Bezouška,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
- MeSH
- biotechnologie metody MeSH
- glykoproteiny biosyntéza chemie metabolismus MeSH
- glykosylace MeSH
- konformace sacharidů MeSH
- molekulární sekvence - údaje MeSH
- oligosacharidy chemie metabolismus MeSH
- pojmy organické chemie MeSH
- polysacharidy chemická syntéza chemie metabolismus MeSH
- sacharidové sekvence MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
The glycan code of glycoproteins can be conceptually defined at molecular level by the sequence of well characterized glycans attached to evolutionarily predetermined amino acids along the polypeptide chain. Functional consequences of protein glycosylation are numerous, and include a hierarchy of properties from general physicochemical characteristics such as solubility, stability and protection of the polypeptide from the environment up to specific glycan interactions. Definition of the glycan code for glycoproteins has been so far hampered by the lack of chemically defined glycoprotein glycoforms that proved to be extremely difficult to purify from natural sources, and the total chemical synthesis of which has been hitherto possible only for very small molecular species. This review summarizes the recent progress in chemical and chemoenzymatic synthesis of complex glycans and their protein conjugates. Progress in our understanding of the ways in which a particular glycoprotein glycoform gives rise to a unique set of functional properties is now having far reaching implications for the biotechnology of important glycodrugs such as therapeutical monoclonal antibodies, glycoprotein hormones, carbohydrate conjugates used for vaccination and other practically important protein-carbohydrate conjugates.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13031932
- 003
- CZ-PrNML
- 005
- 20131002114425.0
- 007
- ta
- 008
- 131002s2012 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.biotechadv.2012.03.008 $2 doi
- 035 __
- $a (PubMed)22484115
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Mrázek, Hynek $u Department of Biochemistry, Faculty of Science, Charles University Prague, Hlavova 8, CZ-12840 Praha 2, Czech Republic.
- 245 10
- $a Carbohydrate synthesis and biosynthesis technologies for cracking of the glycan code: recent advances / $c H. Mrázek, L. Weignerová, P. Bojarová, P. Novák, O. Vaněk, K. Bezouška,
- 520 9_
- $a The glycan code of glycoproteins can be conceptually defined at molecular level by the sequence of well characterized glycans attached to evolutionarily predetermined amino acids along the polypeptide chain. Functional consequences of protein glycosylation are numerous, and include a hierarchy of properties from general physicochemical characteristics such as solubility, stability and protection of the polypeptide from the environment up to specific glycan interactions. Definition of the glycan code for glycoproteins has been so far hampered by the lack of chemically defined glycoprotein glycoforms that proved to be extremely difficult to purify from natural sources, and the total chemical synthesis of which has been hitherto possible only for very small molecular species. This review summarizes the recent progress in chemical and chemoenzymatic synthesis of complex glycans and their protein conjugates. Progress in our understanding of the ways in which a particular glycoprotein glycoform gives rise to a unique set of functional properties is now having far reaching implications for the biotechnology of important glycodrugs such as therapeutical monoclonal antibodies, glycoprotein hormones, carbohydrate conjugates used for vaccination and other practically important protein-carbohydrate conjugates.
- 650 _2
- $a biotechnologie $x metody $7 D001709
- 650 _2
- $a konformace sacharidů $7 D002236
- 650 _2
- $a sacharidové sekvence $7 D002240
- 650 _2
- $a glykoproteiny $x biosyntéza $x chemie $x metabolismus $7 D006023
- 650 _2
- $a glykosylace $7 D006031
- 650 _2
- $a molekulární sekvence - údaje $7 D008969
- 650 _2
- $a oligosacharidy $x chemie $x metabolismus $7 D009844
- 650 _2
- $a pojmy organické chemie $7 D055601
- 650 _2
- $a polysacharidy $x chemická syntéza $x chemie $x metabolismus $7 D011134
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Weignerová, Lenka $u -
- 700 1_
- $a Bojarová, Pavla $u -
- 700 1_
- $a Novák, Petr $u -
- 700 1_
- $a Vaněk, Ondřej $u -
- 700 1_
- $a Bezouška, Karel $u -
- 773 0_
- $w MED00000793 $t Biotechnology advances $x 1873-1899 $g Roč. 31, č. 1 (2012), s. 17-37
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22484115 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20131002 $b ABA008
- 991 __
- $a 20131002114942 $b ABA008
- 999 __
- $a ok $b bmc $g 996019 $s 830377
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 31 $c 1 $d 17-37 $i 1873-1899 $m Biotechnology advances $n Biotechnol Adv $x MED00000793
- LZP __
- $a Pubmed-20131002